Emerging drugs for the treatment of diabetic ulcers

Bibliography

• Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382–7
   PubMed Web of Science ®Google Scholar
• Apelqvist J, Bakker K, van Houtum WH, et al. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International working group on the diabetic foot. Diabetes Metab Res Rev 2000;16(Suppl 1):S84–92
   PubMed Web of Science ®Google Scholar
• Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130:489–93
   PubMed Web of Science ®Google Scholar
• Panuncialman J, Falanga V. The science of wound bed preparation. Surg Clin North Am 2009;89:611–26
   PubMed Web of Science ®Google Scholar
• Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic ulcer study group. J Am Coll Surg 1996;183:61–4
   PubMed Web of Science ®Google Scholar
• Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736–43
   PubMed Web of Science ®Google Scholar
• Falanga V, Sabolinski M. A bilayered living skin construct (apligraf) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999;7:201–7
   PubMed Web of Science ®Google Scholar
• Armstrong DG, Nguyen HC, Lavery LA, et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001;24:1019–22
   PubMed Web of Science ®Google Scholar
• Birke JA FB, Krieger LA, Sliman K. The effectiveness of an accommodative dressing in offloading pressure over areas of previous metatarsal head ulceration. Wounds 2003;15:33–9
   Google Scholar
• Field FK, Kerstein MD. Overview of wound healing in a moist environment. Am J Surg 1994;167:2S–6S
   PubMed Web of Science ®Google Scholar
• Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-bb (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase iii randomized placebo-controlled double-blind study. Diabetes Care 1998;21:822–7
   PubMed Web of Science ®Google Scholar
• Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001;24:290–5
   PubMed Web of Science ®Google Scholar
• Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350–4
   PubMed Web of Science ®Google Scholar
• Muhart M, McFalls S, Kirsner RS, et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites. Arch Dermatol 1999;135:913–18
   PubMed Web of Science ®Google Scholar
• Mueller MJ, Sinacore DR, Hastings MK, et al. Effect of achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 2003;85-A:1436–45
   PubMed Web of Science ®Google Scholar
• Morykwas MJ, Faler BJ, Pearce DJ, Argenta LC. Effects of varying levels of subatmospheric pressure on the rate of granulation tissue formation in experimental wounds in swine. Ann Plast Surg 2001;47:547–51
   PubMed Web of Science ®Google Scholar
• Nather A, Chionh SB, Han AY, et al. Effectiveness of vacuum-assisted closure (vac) therapy in the healing of chronic diabetic foot ulcers. Ann Acad Med Singapore 2010;39:353–8
   PubMed Web of Science ®Google Scholar
• Eginton MT, Brown KR, Seabrook GR, et al. A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann Vasc Surg 2003;17:645–9
   PubMed Web of Science ®Google Scholar
• Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005;366:1704–10
   PubMed Web of Science ®Google Scholar
• Ubbink DT, Westerbos SJ, Evans D, et al. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev 2008;CD001898
   Google Scholar
• Wang C, Schwaitzberg S, Berliner E, et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg 2003;138:272–9. discussion 280
   PubMed Web of Science ®Google Scholar
• Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 1986;121:191–5
   PubMed Web of Science ®Google Scholar
• Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972;135:561–7
   PubMedGoogle Scholar
• Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010;33:998–1003
   PubMed Web of Science ®Google Scholar
• Wang FS, Wang CJ, Chen YJ, et al. Ras induction of superoxide activates erk-dependent angiogenic transcription factor hif-1alpha and vegf-a expression in shock wave-stimulated osteoblasts. J Biol Chem 2004;279:10331–7
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Elster EA, Anam K, et al. Angiogenic response to extracorporeal shock wave treatment in murine skin isografts. Angiogenesis 2008;11:369–80
   PubMed Web of Science ®Google Scholar
• Oi K, Fukumoto Y, Ito K, et al. Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med 2008;214:151–8
   PubMed Web of Science ®Google Scholar
• Saggini R, Figus A, Troccola A, et al. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol 2008;34:1261–71
   PubMed Web of Science ®Google Scholar
• Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in u.S. Adults. The third national health and nutrition examination survey, 1988-1994. Diabetes Care 1998;21:518–24
   PubMed Web of Science ®Google Scholar
• Honeycutt AA, Boyle JP, Broglio KR, et al. A dynamic markov model for forecasting diabetes prevalence in the united states through 2050. Health Care Manag Sci 2003;6:155–64
   PubMedGoogle Scholar
• Margolis DJ, Malay DS, Hoffstad OJ, et al. Economic burden of diabetic foot ulcers and amputations: data points #3. Data points publication series Agency for Healthcare Research and Quality (US); Rockville (MD): 2011
   Google Scholar
• Sivan-Loukianova E, Awad OA, Stepanovic V, et al. Cd34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003;40:368–77
   PubMed Web of Science ®Google Scholar
• Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type ii diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106:2781–6
   PubMed Web of Science ®Google Scholar
• Bauer SM, Goldstein LJ, Bauer RJ, et al. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. J Vasc Surg 2006;43:134–41
   PubMed Web of Science ®Google Scholar
• Lee JA, Conejero JA, Mason JM, et al. Lentiviral transfection with the pdgf-b gene improves diabetic wound healing. Plast Reconstr Surg 2005;116:532–8
   PubMed Web of Science ®Google Scholar
• Lee PY, Chesnoy S, Huang L. Electroporatic delivery of tgf-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol 2004;123:791–8
   PubMed Web of Science ®Google Scholar
• Saaristo A, Tammela T, Farkkila A, et al. Vascular endothelial growth factor-c accelerates diabetic wound healing. Am J Pathol 2006;169:1080–7
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999–1007
   PubMed Web of Science ®Google Scholar
• Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403–9
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701–5
   PubMed Web of Science ®Google Scholar
• Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7:1035–40
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422–7
   PubMed Web of Science ®Google Scholar
• Majka SM, Jackson KA, Kienstra KA, et al. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 2003;111:71–9
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434–8
   PubMed Web of Science ®Google Scholar
• Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002;8:607–12
   PubMed Web of Science ®Google Scholar
• Otani A, Kinder K, Ewalt K, et al. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002;8:1004–10
   PubMed Web of Science ®Google Scholar
• Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194–201
   PubMed Web of Science ®Google Scholar
• Frangioni JV, Beahm PH, Shifrin V, et al. The nontransmembrane tyrosine phosphatase ptp-1b localizes to the endoplasmic reticulum via its 35 amino acid c-terminal sequence. Cell 1992;68:545–60
   PubMed Web of Science ®Google Scholar
• Dube N, Tremblay ML. Involvement of the small protein tyrosine phosphatases tc-ptp and ptp1b in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer. Biochim Biophys Acta 2005;1754:108–17
   PubMed Web of Science ®Google Scholar
• Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, et al. Ptp1b regulates leptin signal transduction in vivo. Dev Cell 2002;2:489–95
   PubMed Web of Science ®Google Scholar
• Cheng A, Uetani N, Simoncic PD, et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1b. Dev Cell 2002;2:497–503
   PubMed Web of Science ®Google Scholar
• Gunaratne P, Stoscheck C, Gates RE, et al. Protein tyrosyl phosphatase-1b is expressed by normal human epidermis, keratinocytes, and a-431 cells and dephosphorylates substrates of the epidermal growth factor receptor. J Invest Dermatol 1994;103:701–6
   PubMed Web of Science ®Google Scholar
• Sreejayan N, Lin Y, Hassid A. No attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1b-mediated mechanism. Arterioscler Thromb Vasc Biol 2002;22:1086–92
   PubMed Web of Science ®Google Scholar
• Trop S, Tremblay ML, Bourdeau A. Modulation of bone marrow-derived endothelial progenitor cell activity by protein tyrosine phosphatases. Trends Cardiovasc Med 2008;18:180–6
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Patrushev N, Inomata H, et al. Role of protein tyrosine phosphatase 1b in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res 2008;102:1182–91
   PubMedGoogle Scholar
• Stenzinger A, Schreiner D, Pfeiffer T, et al. Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin d3-regulated expression of the novel protein ptpip51 in keratinocytes. Cells Tissues Organs 2006;184:76–87
   PubMed Web of Science ®Google Scholar
• Pu Q, Chang Y, Zhang C, et al. Chronic insulin treatment suppresses ptp1b function, induces increased pdgf signaling, and amplifies neointima formation in the balloon-injured rat artery. Am J Physiol Heart Circ Physiol 2009;296:H132–9
   PubMed Web of Science ®Google Scholar
• Lanahan AA, Hermans K, Claes F, et al. Vegf receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev Cell 2010;18:713–24
   Google Scholar
• Oshikawa J, Urao N, Kim HW, et al. Extracellular sod-derived h2o2 promotes vegf signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS ONE 2010;5:e10189
   PubMed Web of Science ®Google Scholar
• Chang Y, Ceacareanu B, Zhuang D, et al. Counter-regulatory function of protein tyrosine phosphatase 1b in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Arterioscler Thromb Vasc Biol 2006;26:501–7
   PubMed Web of Science ®Google Scholar
• Kakazu A, Sharma G, Bazan HE. Association of protein tyrosine phosphatases (ptps)-1b with c-met receptor and modulation of corneal epithelial wound healing. Invest Ophthalmol Vis Sci 2008;49:2927–35
   PubMed Web of Science ®Google Scholar
• El Sayegh TY, Kapus A, McCulloch CA. Beyond the epithelium: cadherin function in fibrous connective tissues. FEBS Lett 2007;581:167–74
   PubMed Web of Science ®Google Scholar
• Quattrini C, Jeziorska M, Malik RA. Small fiber neuropathy in diabetes: clinical consequence and assessment. Int J Low Extrem Wounds 2004;3:16–21
   PubMedGoogle Scholar
• Nakamura M, Kawahara M, Morishige N, et al. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance p-derived peptide (fglm-nh2) and insulin-like growth factor-1. Diabetologia 2003;46:839–42
   PubMed Web of Science ®Google Scholar
• Movafagh S, Hobson JP, Spiegel S, et al. Neuropeptide y induces migration, proliferation, and tube formation of endothelial cells bimodally via y1, y2, and y5 receptors. FASEB J 2006;20:1924–6
   PubMed Web of Science ®Google Scholar
• Ekstrand AJ, Cao R, Bjorndahl M, et al. Deletion of neuropeptide y (npy) 2 receptor in mice results in blockage of npy-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 2003;100:6033–8
   PubMed Web of Science ®Google Scholar
• Kuo LE, Abe K, Zukowska Z. Stress, npy and vascular remodeling: implications for stress-related diseases. Peptides 2007;28:435–40
   PubMed Web of Science ®Google Scholar
• Delgado AV, McManus AT, Chambers JP. Exogenous administration of substance p enhances wound healing in a novel skin-injury model. Exp Biol Med (Maywood) 2005;230:271–80
   PubMed Web of Science ®Google Scholar
• Zukowska Z, Grant DS, Lee EW. Neuropeptide y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 2003;13:86–92
   PubMed Web of Science ®Google Scholar
• Hokfelt T, Kellerth JO, Nilsson G, Pernow B. Substance p: localization in the central nervous system and in some primary sensory neurons. Science 1975;190:889–90
   PubMed Web of Science ®Google Scholar
• Harrison S, Geppetti P. Substance p. Int J Biochem Cell Biol 2001;33:555–76
   PubMed Web of Science ®Google Scholar
• Khawaja AM, Rogers DF. Tachykinins: receptor to effector. Int J Biochem Cell Biol 1996;28:721–38
   PubMed Web of Science ®Google Scholar
• Pernow B. Substance p. Pharmacol Rev 1983;35:85–141
   PubMed Web of Science ®Google Scholar
• Lindberger M, Schroder HD, Schultzberg M, et al. Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci 1989;93:289–96
   PubMed Web of Science ®Google Scholar
• Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al. Neuropeptide y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998;83:187–95
   PubMed Web of Science ®Google Scholar
• Wallengren J, Badendick K, Sundler F, et al. Innervation of the skin of the forearm in diabetic patients: Relation to nerve function. Acta Derm Venereol 1995;75:37–42
   PubMed Web of Science ®Google Scholar
• Toda M, Suzuki T, Hosono K, et al. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother 2008;62:352–9
   PubMed Web of Science ®Google Scholar
• Oltman CL, Davidson EP, Coppey LJ, et al. Treatment of zucker diabetic fatty rats with ave7688 improves vascular and neural dysfunction. Diabetes Obes Metab 2009;11:223–33
   PubMed Web of Science ®Google Scholar
• Hatanaka E, Monteagudo PT, Marrocos MS, Campa A. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 2006;146:443–7
   PubMed Web of Science ®Google Scholar
• Fisman EZ, Adler Y, Tenenbaum A. Biomarkers in cardiovascular diabetology: interleukins and matrixins. Adv Cardiol 2008;45:44–64
   PubMed Web of Science ®Google Scholar
• Mastej K, Adamiec R. Neutrophil surface expression of cd11b and cd62l in diabetic microangiopathy. Acta Diabetol 2008;45:183–90
   PubMed Web of Science ®Google Scholar
• Stegenga ME, van der Crabben SN, Dessing MC, et al. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008;25:157–64
   PubMed Web of Science ®Google Scholar
• Oncul O, Yildiz S, Gurer US, et al. Effect of the function of polymorphonuclear leukocytes and interleukin-1 beta on wound healing in patients with diabetic foot infections. J Infect 2007;54:250–6
   PubMed Web of Science ®Google Scholar
• Ochoa O, Torres FM, Shireman PK. Chemokines and diabetic wound healing. Vascular 2007;15:350–5
   PubMed Web of Science ®Google Scholar
• Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes 2012;61:2937–47
   PubMed Web of Science ®Google Scholar
• Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856–62
   PubMed Web of Science ®Google Scholar
• Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457–63
   PubMed Web of Science ®Google Scholar
• Menzoian JO, LaMorte WW, Paniszyn CC, et al. Symptomatology and anatomic patterns of peripheral vascular disease: differing impact of smoking and diabetes. Ann Vasc Surg 1989;3:224–8
   PubMedGoogle Scholar
• Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 2002;35:501–5
   PubMed Web of Science ®Google Scholar
• Boska M. Estimating the atp cost of force production in the human gastrocnemius/soleus muscle group using 31p mrs and 1h mri. NMR Biomed 1991;4:173–81
   PubMed Web of Science ®Google Scholar
• Greenman RL, Panasyuk S, Wang X, et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 2005;366:1711–17
   PubMed Web of Science ®Google Scholar
• Greenman RL, Rakow-Penner R. Evaluation of the rf field uniformity of a double-tuned 31p/1h birdcage rf coil for spin-echo mri/mrs of the diabetic foot. J Magn Reson Imaging 2005;22:427–32
   PubMed Web of Science ®Google Scholar
• Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37:307–15
   PubMed Web of Science ®Google Scholar
• Greenman RL. Quantification of the 31p metabolite concentration in human skeletal muscle from rare image intensity. Magn Reson Med 2004;52:1036–42
   PubMed Web of Science ®Google Scholar
• Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic ulcer study group. J Vasc Surg 1995;21:71–8. discussion 79-81
   PubMed Web of Science ®Google Scholar
• Villela DL, Santos VL. Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth factors 2010;28:111–16
   PubMed Web of Science ®Google Scholar
• Saad Setta H, Elshahat A, Elsherbiny K, et al. Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study. Int Wound J 2011;8:307–12
   PubMed Web of Science ®Google Scholar
• Balingit PP, Armstrong DG, Reyzelman AM, et al. Norleu3-a(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial. Wound Repair Regen 2012;20:482–90
   PubMed Web of Science ®Google Scholar
• Bowen-Pope DF, Malpass TW, Foster DM, Ross R. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. Blood 1984;64:458–69
   PubMed Web of Science ®Google Scholar
• Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996;94:1074–82
   PubMed Web of Science ®Google Scholar